Kidney

The Global Renal Dialysis Market is expected to grow by $ 31.71 bn during 2020-2024 progressing at a CAGR of 6% during the forecast period

Thursday, May 28, 2020 - 7:00pm

The analyst has been monitoring the renal dialysis market and it is poised to grow by $ 31.71 bn during 2020-2024 progressing at a CAGR of 6% during the forecast period.

Key Points: 
  • The analyst has been monitoring the renal dialysis market and it is poised to grow by $ 31.71 bn during 2020-2024 progressing at a CAGR of 6% during the forecast period.
  • Our reports on renal dialysis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
  • The renal dialysis market is segmented as below:

United States Nephrology and Urology Devices Market Outlook to 2025 with Focus on Renal Dialysis Equipment - ResearchAndMarkets.com

Thursday, May 28, 2020 - 12:04pm

This comprehensive databook report covers key market data on the United States Nephrology and Urology Devices market.

Key Points: 
  • This comprehensive databook report covers key market data on the United States Nephrology and Urology Devices market.
  • The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Renal Dialysis Equipment.
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Nephrology and Urology Devices Market.

The Europe millets market was valued at US$ 1,327.96 million in 2018 and is expected to grow at a CAGR of 5.4% from 2019 to2027 to reach US$ 2,132.00 million by 2027

Saturday, May 23, 2020 - 2:05am

The Europe millets market was valued at US$ 1,327.96 million in 2018 and is expected to grow at a CAGR of 5.4% from 2019 to2027 to reach US$ 2,132.00 million by 2027.

Key Points: 
  • The Europe millets market was valued at US$ 1,327.96 million in 2018 and is expected to grow at a CAGR of 5.4% from 2019 to2027 to reach US$ 2,132.00 million by 2027.
  • Millets are an ideal food for people suffering from chronic diseases such as diabetes and heart diseases.
  • Regular consumption of millets helps in preventing gastrointestinal problems and other diseases related to kidney and liver.
  • Some of the players present in the Europe millets market are Just Organik, Shimla Hills Offerings Pvt.Ltd, Sresta Natural Bioproducts Pvt.

Nation's Largest Kidney Patient and Professional Organizations Urge Action to Protect Patients During Reopening

Thursday, May 21, 2020 - 3:54pm

"Kidney patients continue to be extremely vulnerable to severe COVID-19 infection and we must take every precaution to help protect them as the country reopens," said Kevin Longino, CEO of National Kidney Foundation and a kidney transplant patient.

Key Points: 
  • "Kidney patients continue to be extremely vulnerable to severe COVID-19 infection and we must take every precaution to help protect them as the country reopens," said Kevin Longino, CEO of National Kidney Foundation and a kidney transplant patient.
  • "While kidney patients should continue to shelter in place during reopening; they also need access to a healthcare system which can support their need to isolate and socially distance.
  • "The Administration moved quickly and decisively to address the safe continuity of care for people with kidney diseases.
  • "We sincerely thank the Administration for their efforts thus far to protect kidney patients and look forward to working closely with them to implement our recommendations."

Renal Support Network Announces 18th Annual Essay Contest Theme

Wednesday, May 20, 2020 - 6:00pm

GLENDALE, Calif., May 20, 2020 /PRNewswire-PRWeb/ -- Renal Support Network (RSN), a nonprofit, patient-run organization, encourages people with kidney disease to share their inspirational stories by entering their 18th Annual Essay Contest.

Key Points: 
  • GLENDALE, Calif., May 20, 2020 /PRNewswire-PRWeb/ -- Renal Support Network (RSN), a nonprofit, patient-run organization, encourages people with kidney disease to share their inspirational stories by entering their 18th Annual Essay Contest.
  • This year's theme is "Thriving No Matter What I Can or Can't Eat: A Happy Food Experience on the Kidney Diet."
  • For information about the contest, rules and to read previous winning essays, visit RSN's Essay Contest Web Page
    RSN would like to thank Akebia, Fresenius Kidney Care, National Renal Administrators Association and U.S. Renal Care for their support of this valuable patient engagement program.
  • The Renal Support Network (RSN) is a nonprofit patient-run organization that provides non-medical services to those affected by chronic kidney disease.

Humana and Healthmap Solutions Sign Agreement for Kidney Disease Care Coordination Services in Florida

Wednesday, May 20, 2020 - 2:00pm

(NYSE: HUM) and Healthmap Solutions, Inc. , a specialty population health management company with kidney health expertise, today announced a collaboration to provide care coordination services for Humana Medicare Advantage and Commercial members in Florida who have kidney disease.

Key Points: 
  • (NYSE: HUM) and Healthmap Solutions, Inc. , a specialty population health management company with kidney health expertise, today announced a collaboration to provide care coordination services for Humana Medicare Advantage and Commercial members in Florida who have kidney disease.
  • In conjunction with the patient's primary care physician, nephrologist, or other specialists, Healthmap Solutions works to eliminate gaps in care through a patient-centric approach, streamlining provider communication and coordinating care.
  • Healthmap Solutions is a specialty population health management company with a specific Kidney Health Management (KHM) solution for patients with kidney disease, serving health plans, as well as accountable care organizations (ACOs) and provider groups seeking value-based solutions that improve the clinical care and financial performance for high-risk, high-cost kidney patient populations.
  • Today Healthmap Solutions uses that experience to power a complex Kidney Health Management program with its clinical experts.

Analysis on Impact of Covid-19- Renal Dialysis Market 2020-2024 | Increasing Number of ESRD Patients to Boost Growth | Technavio

Wednesday, May 20, 2020 - 1:30pm

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43740

Key Points: 
  • To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43740
    Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.
  • Our renal dialysis market report covers the following areas:
    This study identifies the prevalence of diabetes and hypertension as one of the prime reasons driving the renal dialysis market growth during the next few years.
  • Backed with competitive intelligence and benchmarking, our research reports on the Renal Dialysis Market are designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

 First Large-scale Study Links Acute Kidney Injury and COVID-19 Hospitalizations

Thursday, May 14, 2020 - 8:47pm

Kenar Jhaveri and Steven Fishbane doing rounds at North Shore University Hospital on COVID-19 patients with acute kidney injury.

Key Points: 
  • Kenar Jhaveri and Steven Fishbane doing rounds at North Shore University Hospital on COVID-19 patients with acute kidney injury.
  • Among patients with AKI at the studys conclusion, 39.1 percent (780 out of 1,993) were still hospitalized.
  • AKI is a sudden episode of kidney failure or damage, preventing waste from being filtered within the body and can often lead to death.
  • Most cases developed early in a patients hospitalization, with 37.3 percent either arriving with AKI or developing it within 24 hours.

End Stage Renal Disease Market Size Worth $172.0 Billion by 2027: Grand View Research, Inc.

Wednesday, May 13, 2020 - 9:05am

SAN FRANCISCO, May 13, 2020 /PRNewswire/ -- The global end stage renal disease market size is anticipated to reach USD 172.0 billion by 2027, exhibiting a CAGR of 12.4% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from kidney failure or end stage renal disease and rising prevalence of hypertension and diabetes are driving the market for end stage renal disease.

Key Points: 
  • SAN FRANCISCO, May 13, 2020 /PRNewswire/ -- The global end stage renal disease market size is anticipated to reach USD 172.0 billion by 2027, exhibiting a CAGR of 12.4% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from kidney failure or end stage renal disease and rising prevalence of hypertension and diabetes are driving the market for end stage renal disease.
  • Chronic kidney disease (CKD) is one of the major causes of increase in the kidney failure rates among patients.
  • Thus, WAK has the potential to reduce mortality in dialysis patients, thereby improving an end stage renal disease patient's quality of life.
  • Grand View Research has segmented the global end stage renal disease market on the basis of treatment and region:
    End Stage Renal Disease Treatment Outlook (Revenue, USD Million, 2016 - 2027)

End Stage Renal Disease Market Size Worth $172.0 Billion by 2027: Grand View Research, Inc.

Wednesday, May 13, 2020 - 9:05am

SAN FRANCISCO, May 13, 2020 /PRNewswire/ -- The global end stage renal disease market size is anticipated to reach USD 172.0 billion by 2027, exhibiting a CAGR of 12.4% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from kidney failure or end stage renal disease and rising prevalence of hypertension and diabetes are driving the market for end stage renal disease.

Key Points: 
  • SAN FRANCISCO, May 13, 2020 /PRNewswire/ -- The global end stage renal disease market size is anticipated to reach USD 172.0 billion by 2027, exhibiting a CAGR of 12.4% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from kidney failure or end stage renal disease and rising prevalence of hypertension and diabetes are driving the market for end stage renal disease.
  • Chronic kidney disease (CKD) is one of the major causes of increase in the kidney failure rates among patients.
  • Thus, WAK has the potential to reduce mortality in dialysis patients, thereby improving an end stage renal disease patient's quality of life.
  • Grand View Research has segmented the global end stage renal disease market on the basis of treatment and region:
    End Stage Renal Disease Treatment Outlook (Revenue, USD Million, 2016 - 2027)